Allstate Investment Management’s Bio-Techne TECH Stock Holding History

Allstate Investment Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$651K	Buy	+7,860	New	+$624K	0.02%	444

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Allstate Investment Management's TECH Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Bio-Techne (TECH) in Q4 2022: 7,860 shares worth $651K. The stake represents 0.02% of the portfolio and ranks #444 among its holdings.

545 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

Allstate Investment Management held 7,860 shares of Bio-Techne worth $651K as of Q4 2022.
Bio-Techne was a new Allstate Investment Management position in Q4 2022.
Bio-Techne made up 0.02% of Allstate Investment Management's portfolio in Q4 2022, its #444 holding.
545 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.